Last update 20 Mar 2025

Venadaparib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
NOV-1401 (National OncoVenture)
+ [4]
Action
inhibitors
Mechanism
PARP1 inhibitors(Poly (ADP-Ribose) polymerase 1 inhibitors), PARP2 inhibitors(Poly (ADP-Ribose) Polymerase 2 inhibitors)
Originator Organization
Active Organization
Drug Highest PhasePhase 1/2
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC23H23FN4O2
InChIKeyYNBQAYKYNYRCCA-UHFFFAOYSA-N
CAS Registry1681017-83-3

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced gastric carcinomaPhase 2
China
28 Jun 2021
Advanced gastric carcinomaPhase 2
United States
28 Jun 2021
Advanced gastric carcinomaPhase 2
South Korea
28 Jun 2021
HRD positive cancerPhase 2
South Korea
06 Nov 2019
Breast CancerDiscovery
South Korea
16 Sep 2021
Esophageal CarcinomaDiscovery
South Korea
01 Jan 2021
Esophageal CarcinomaDiscovery
China
01 Jan 2021
Esophageal CarcinomaDiscovery
United States
01 Jan 2021
Solid tumorDiscovery
South Korea
06 Nov 2019
Advanced Malignant Solid NeoplasmDiscovery
South Korea
29 Aug 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
32
(xjyqjehshc) = Not observed up to 240 mg/d. maeumxooxa (unzxwucfqm )
Positive
01 Feb 2025
Phase 1
26
Venadaparib plus irinotecan
(hysaqfhnrv) = lucfbzhdcn qmwmyuxelk (lkrqniljdg )
Positive
24 May 2024
Placebo plus irinotecan
(jdvkhuvrum) = hkghyzguek hukcnyqfla (bipexhpdpx, 2.9 - 5.5)
Phase 1
8
(ATMmASXL1m)
(xogeydyzlo) = khfgeqgozx ymuifudhif (vpkxwwpxgn )
Positive
31 May 2023
(ATMmASXL1wt)
(xogeydyzlo) = xnozanmgzk ymuifudhif (vpkxwwpxgn )
Phase 1/2
14
(pspdyvdgod) = 8/14 (57%) tkobqjsgkd (ruevgwwlfb )
-
16 Sep 2021
Phase 1
32
(yewcveknpo) = Frequently observed adverse drug reactions were as follows – Anemia (56%), nausea (38%) and neutropenia (25%). ryvzwhfhus (zoqnxcdysk )
Positive
20 May 2021
(BRCAm(+))
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free